菜单

Supply Chain Intelligence about:

Sanofi Aventis Uruguay S.A.

企业页面   Uruguay

See Sanofi Aventis Uruguay S.A.'s products and suppliers

成千上万家像您这样的公司使用磐聚网搜索供应商和竞争对手。

轻松使用贸易数据

14美国进口货运
US
19 南美货运信息
南美

以公司为组织的美国海关记录

14 U.S. shipments available for Sanofi Aventis Uruguay S.A., updated weekly since 2007
日期 供应商 客户 详细信息 43 more fields
2015-02-11 Sanofi Aventis De Mexico SA De Cv
Sanofi Aventis Uruguay S.A.
XXX XXXXXXXXXXX XXXXXX XXXX XXX XX XXXXXXXXXX XXXXXXXX XXXXXXXXXXX XX XX XXXXX XXXX
货运提单
2014-09-25 Sanofi Aventis De Mexico SA De Cv
Sanofi Aventis Uruguay S.A.
XXXXXX XXXX XXX XX XXXXXXXXX XXXXXXXX XX XXXXX XXX XXXXX XXXXX XXXX
货运提单
2014-08-25 Sanofi Aventis De Mexico SA De Cv
Sanofi Aventis Uruguay S.A.
XXXX XXXXXXXXXXXX XXXXXX XXXX XXX XX XXXXXXXXX XXXXXXXX XX XXXXX XXX XXXXX XXXXX XXXX
货运提单
货运数据显示一个公司交易什么产品或者更多。 了解更多信息

Explore trading relationships hidden in supply chain data

Contact information for Sanofi Aventis Uruguay S.A.

 
地址
Ellauri 938, Montevideo, Uruguay, 11300
 
 

Sample Bill of Lading

61 shipment records available

Date
2015-02-11
Shipper Name
Sanofi Aventis De Mexico
Shipper Address
AVENIDA UNIVERSIDAD 1738 COLONIA COYOACáN MEXICO CITY, DISTRITO FEDERAL 4000
Consignee Name
Sanofi Aventis Uruguay S.A.
Consignee Address
Ellauri 938, Montevideo, Uruguay, 11300
Weight
11343
Weight Unit
KG
Weight in KG
11343.0
Quantity
25
Quantity Unit
PKG
Measure Unit
CM
Shipment Origin
Mexico
Details
11,343.0 kg
From port: Veracruz, Mexico
To port: Houston, Houston, Texas
Place of Receipt
Ocoyoacac
Foreign Port of Lading
Veracruz, Mexico
U.S. Port of Unlading
Houston, Houston, Texas
U.S. Destination Port
Houston, Houston, Texas
Commodity
XXX XXXXXXXXXXX XXXXXX XXXX XXX XX XXXXXXXXXX XXXXXXXX XXXXXXXXXXX XX XX XXXXX XXXX
Container
TCNU7110920
Marks Description
XXX XXX
Carrier Name
PANTAINER EXPRESS LINE PANALPINA INC AS AGENTS
Vessel Name
ER DENMARK
Voyage Number
1506S
Bill of Lading Number
PNEP65722062199
Master Bill of Lading Number
CPLBKRCAVXR00
HTS Codes
HTS 3004.90

Recent Panjiva Research about Sanofi Aventis Uruguay S.A.

20161202-insulin-us

Novo and Lilly Face Tough Growth in Diabetes, Trade Data Shows

The global prevalence of diabetes is growing, but can be a tough sector for pharmaceutical companies to make money in as recent results from Novo Nordisk and Eli Lilly demonstrate. Panjiva data shows that U.S. imports of insulin and related equipment fell 15% in the third quarter in dollar ter... Read more →